| 2020 |
WDR6 is an interacting protein of FTSJ1 (human TRM7 ortholog), and the FTSJ1-WDR6 complex reconstituted in vitro catalyzes 2'-O-methylation at position 34 of specific tRNAs, with m1G37 as a prerequisite for this activity. |
Co-immunoprecipitation to identify interaction; in vitro reconstitution of methyltransferase activity; genetic knockout of ftsj1 to assess modification loss |
EMBO reports |
High |
32558197
|
| 2014 |
Yeast Trm734 (WDR6 ortholog) forms a complex with Trm7 to specifically 2'-O-methylate position 34 (N34) of tRNA anticodon loop substrates including tRNAPhe, tRNATrp, and tRNALeu; this is distinct from the Trm7-Trm732 complex which methylates position 32. |
Genetic complementation assays in S. cerevisiae and S. pombe deletion mutants; tRNA modification analysis; growth phenotype rescue experiments |
RNA (New York, N.Y.) |
High |
25404562 25625329
|
| 2015 |
Defects in the Trm7-Trm734 (WDR6 ortholog) complex result in loss of Gm34 on tRNAPhe, and a FTSJ1-p.A26P missense mutation (corresponding to nonsyndromic X-linked intellectual disability) specifically abolishes Gm34 without affecting Cm32; the reduced Gm34 is not due to weaker Trm734 binding to Trm7. |
LC-MS/MS tRNA modification analysis from patient cell lines and yeast trm7-A26P mutant; yeast complementation assays; binding assays |
Human mutation |
High |
26310293
|
| 2019 |
Crystal structure of the yeast Trm7-Trm734 (WDR6 ortholog) complex reveals Trm734 consists of three WD40 β-propeller domains (BPA, BPB, BPC); BPA and BPC form a V-shaped cleft that docks to Trm7; the C-terminal region of Trm7 is required for Trm734 binding; Trm734's BPB domain positions tRNA D-arm, placing the anticodon loop near Trm7's catalytic pocket; the complex is a heterodimer in solution. |
X-ray crystallography (apo and SAM-bound forms); SAXS; in vitro methylation assays with tRNA variants; mutagenesis of Trm7 and tRNA substrates |
Nucleic acids research |
High |
31586407
|
| 2025 |
The human FTSJ1-WDR6 complex (distinct from FTSJ1-THADA) mediates Nm34 modification; cryo-EM structure of the FTSJ1-THADA complex reveals FTSJ1 binds THADA via its C-terminal region with an interaction mode distinct from the FTSJ1-WDR6 complex, confirming that WDR6 and THADA occupy distinct functional niches as auxiliary subunits of FTSJ1. |
Cryo-electron microscopy structure determination; biochemical interaction analyses; comparison with previously solved FTSJ1-WDR6 structure |
Communications biology |
Medium |
40483304
|
| 2024 |
Specific amino acids in Trm734 (WDR6 ortholog) located near the active site of Trm7 (not at the Trm7-Trm734 protein-protein interface) are required for tRNA modification activity; a nonfunctional but stable Trm734 variant was identified, suggesting these residues may be important for tRNA binding rather than protein complex assembly. |
Site-directed mutagenesis of Trm734; yeast functional complementation assays; immunoprecipitation to verify Trm7-Trm734 binding; structural mapping onto published crystal structure |
ACS omega |
Medium |
38882062
|
| 2007 |
WDR6 interacts with LKB1 (STK11) and is localized in the cytoplasm co-incident with LKB1; co-expression of WDR6 with LKB1 enhances LKB1-mediated inhibition of HeLa cell proliferation, synergizes to induce G1 cell cycle arrest, and elevates p27(Kip1) protein and promoter activity beyond the effect of LKB1 alone. |
Yeast two-hybrid screening; immunofluorescence co-localization; colony formation assay; cell cycle analysis; p27(Kip1) promoter-reporter assay; co-expression in HeLa cells |
Molecular and cellular biochemistry |
Medium |
17216128
|
| 2007 |
WDR6 interacts with insulin receptor substrate 4 (IRS-4) in rat brain hypothalamus; WDR6 mRNA is abundantly expressed in the hypothalamus and is decreased by caloric restriction and in GH-antisense transgenic rats (both associated with increased lifespan); IGF-I and insulin treatment increase WDR6 gene expression in hypothalamic GT1-7 cells. |
Suppression subtractive hybridization; co-immunoprecipitation/interaction assay from rat brain; in vitro stimulation of GT1-7 cells with IGF-I/insulin |
Neurobiology of aging |
Low |
17720279
|
| 2019 |
WDR6 is a component of a Cullin4-DDB1-WDR6 E3 ubiquitin ligase complex that binds SPAK and OSR1 kinases in a phosphorylation-dependent manner (dependent on S-motif phosphorylation); this binding is reduced under osmotic stress when the S-motif is phosphorylated, and OSR1 ubiquitylation is abolished under osmotic stress. |
Affinity pull-down; mass spectrometry; proteasomal and neddylation inhibitor treatment; osmotic stress experiments |
Chembiochem |
Medium |
31614064
|
| 2023 |
WDR6 promotes hepatic de novo lipogenesis during insulin resistance by interacting with PPP1CB (PP1β catalytic subunit) to facilitate PPP1CB dephosphorylation at Thr316, which subsequently enhances fatty acid synthase transcription through DNA-dependent protein kinase and upstream stimulatory factor 1. |
Co-immunoprecipitation; molecular dynamics simulation; in vivo mouse models of insulin resistance; siRNA knockdown and overexpression; transcription reporter assays |
Nature metabolism |
Medium |
37735236
|
| 2023 |
WDR6 promotes UVRAG degradation by recruiting it to the CUL4A-DDB1-ROC1 E3 ubiquitin ligase complex through a WDxR motif; WDR6 deficiency in HCC cells reduces tumor growth and lung metastasis in immunocompetent mice but not in vitro, linked to blocking autophagic degradation of p65, elevating TNFα, increasing MDSCs, and reducing CD8+ T cell infiltration; TNFα activates NF-κB to transcribe WDR6, establishing a feedback loop. |
CRISPR/Cas9 knockout; co-immunoprecipitation; in vivo orthotopic tumor implantation in C57BL/6J mice; chromatin accessibility assays; flow cytometry for immune cell analysis; TNFα blockade experiments; peptide disruption assay |
EMBO molecular medicine |
Medium |
36947051
|
| 2015 |
WDR6 was identified as a restriction factor that inhibits replication of vaccinia virus K1L-C7L double deletion mutant in human cells; CRISPR/Cas9 knockout of WDR6 in HeLa cells permitted enhanced replication of the mutant virus; WDR6 acts independently of SAMD9 (interactions of WDR6 with SAMD9, C7, and K1 proteins were not detected), and WDR6 knockout did not reduce SAMD9 levels. |
Genome-wide siRNA screen; CRISPR/Cas9 knockout of WDR6 in HeLa cells; viral replication assays; immunoprecipitation (negative for WDR6-SAMD9/C7/K1 interactions) |
mBio |
Medium |
26242627
|
| 2000 |
Human WDR6 encodes a protein of 1121 amino acids containing 11 WD-repeat units clustered in two groups separated by a putative transmembrane domain; the gene maps to chromosome 15q21 and is ubiquitously expressed in human adult and fetal tissues. |
Molecular cloning; Northern blot analysis; fluorescence in situ hybridization (FISH) |
Biochemical and biophysical research communications |
Medium |
10903905
|